Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedicalCV was a cardiovascular medical device company specializing in treatments for atrial fibrillation and heart valve disorders. The company's primary products included the Omnicarbon mechanical heart valve and the AtriLaze and Solar surgical ablation systems, which utilized laser energy for cardiac tissue ablation. Following financial difficulties and a Chapter 11 bankruptcy filing, the company's assets were acquired by AtriCure in 2008 for approximately $2.1 million. The remaining corporate shell eventually transitioned into a media company named Universal Media Group. During its operation, MedicalCV was a pioneer in laser-based surgical ablation for the treatment of arrhythmias.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedicalCV.